J

Jade Biosciences Inc
D

JBIO

19.640
USD
-0.19
(-0.96%)
مغلق
حجم التداول
11,518
الربح لكل سهم
-2
العائد الربحي
-
P/E
-7
حجم السوق
1,195,287,945
أصول ذات صلة المقالات
المزيد

العنوان: Jade Biosciences Inc

القطاع: Healthcare
الصناعة: Biotechnology
Jade Biosciences Inc is a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases. Its flagship candidate, JADE101, targets the cytokine APRIL and is in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. The company's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, and JADE301, an antibody candidate in preclinical development.